Skip to main content
SpringerLink
Log in

Prevalence and severity of cancer therapy-induced cardiotoxicity

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. cardiotoxicity

Reference

  • Lopez-Sendon J, et al. Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry. European Heart Journal : 4 Feb 2020. Available from: URL: http://doi.org/10.1093/eurheartj/ehaa006

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prevalence and severity of cancer therapy-induced cardiotoxicity. Reactions Weekly 1791, 12 (2020). https://doi.org/10.1007/s40278-020-74857-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-74857-5

Search

Navigation